Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus
- PMID: 15901790
- PMCID: PMC6724863
- DOI: 10.1523/JNEUROSCI.0360-05.2005
Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus
Abstract
High-frequency stimulation of the subthalamic nucleus (HFS-STN) is an effective treatment for alleviating the motor symptoms of parkinsonian patients. However, the neurochemical basis of its effects remains unknown. We showed previously that 1 h of HFS-STN in normal rats increases extracellular glutamate (Glu) level in the output nuclei of the STN, the globus pallidus (GP), and the substantia nigra pars reticulata (SNr), consistent with an increase in the activity of STN neurons. HFS-STN also increases GABA levels in the SNr, but the origin of this increase is unclear. We investigated the effectiveness of HFS-STN for improving Parkinson's disease symptoms, using intracerebral microdialysis to determine the extracellular Glu and GABA levels of the GP and SNr in response to HFS-STN in anesthetized hemiparkinsonian rats [6-hydroxydopamine lesion of the substantia nigra pars compacta (SNc)]. Basal levels of Glu and GABA in the GP and SNr were significantly higher in hemiparkinsonian than in intact rats. HFS-STN did not affect extracellular Glu level in the SNr of hemiparkinsonian rats but doubled the level of GABA. Ibotenic acid lesion of the GP abolished the increase in GABA levels in the SNr induced by HFS-STN in SNc-lesioned rats. These results provide neurochemical confirmation of the hyperactivity of the STN after dopaminergic denervation and suggest that the therapeutic effects of HFS-STN may result partly from the stimulation of pallidonigral fibers, thereby revealing a potential role for pallidal GABA in the inhibition of basal ganglial output structures during HFS-STN.
Figures
Similar articles
-
Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.J Neurosci. 2006 Oct 18;26(42):10768-76. doi: 10.1523/JNEUROSCI.3065-06.2006. J Neurosci. 2006. PMID: 17050715 Free PMC article.
-
Influence of the frequency parameter on extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats.J Neurosci Res. 2003 Apr 15;72(2):259-67. doi: 10.1002/jnr.10577. J Neurosci Res. 2003. PMID: 12672001
-
Change of extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in epileptic rats.Stereotact Funct Neurosurg. 2008;86(4):208-15. doi: 10.1159/000131657. Epub 2008 May 13. Stereotact Funct Neurosurg. 2008. PMID: 18480598
-
Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.J Neurochem. 2016 Mar;136(5):1004-16. doi: 10.1111/jnc.13438. Epub 2015 Dec 21. J Neurochem. 2016. PMID: 26576509
-
Intrinsic and integrative properties of substantia nigra pars reticulata neurons.Neuroscience. 2011 Dec 15;198:69-94. doi: 10.1016/j.neuroscience.2011.07.061. Epub 2011 Aug 2. Neuroscience. 2011. PMID: 21839148 Free PMC article. Review.
Cited by
-
The effects of bioactive components from the rhizome of gastrodia elata blume (Tianma) on the characteristics of Parkinson's disease.Front Pharmacol. 2022 Nov 30;13:963327. doi: 10.3389/fphar.2022.963327. eCollection 2022. Front Pharmacol. 2022. PMID: 36532787 Free PMC article. Review.
-
Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.J Neuroimmune Pharmacol. 2021 Jun;16(2):454-469. doi: 10.1007/s11481-020-09934-7. Epub 2020 Jul 9. J Neuroimmune Pharmacol. 2021. PMID: 32648088 Free PMC article.
-
Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.J Neurosci. 2020 May 27;40(22):4323-4334. doi: 10.1523/JNEUROSCI.3071-19.2020. Epub 2020 Apr 20. J Neurosci. 2020. PMID: 32312888 Free PMC article.
-
An update on best practice of deep brain stimulation in Parkinson's disease.Ther Adv Neurol Disord. 2019 Mar 28;12:1756286419838096. doi: 10.1177/1756286419838096. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30944587 Free PMC article. Review.
-
Evidence for a task-dependent switch in subthalamo-nigral basal ganglia signaling.Nat Commun. 2017 Oct 19;8(1):1039. doi: 10.1038/s41467-017-01023-3. Nat Commun. 2017. PMID: 29051496 Free PMC article.
References
-
- Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375. - PubMed
-
- Alexander GE, Crutcher DM (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13: 266-271. - PubMed
-
- Aziz TZ, Peggs D, Sambrook MA, Crossman AR (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tethrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6: 288-292. - PubMed
-
- Benabid AL, Benazzouz A, Pollak P (2002) Mechanisms of deep brain stimulation. Mov Disord 17: S73-S74. - PubMed
-
- Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5: 382-389. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous